781 A randomized phase II trial of gemcitabine and either day 1 or day 8 carboplatin for advanced non-small cell lung cancer (NSCLC)

Autor:	Jose Iglesias, W.I. Burns, F. Abell, F. Kirsten, W.H.H. Reece, C. Crombie, R.M. Lowenthal, P. DeSouza, J.A. Davidson, C. Karapetis
Rok vydání:	2003
Předmět:	Oncology Cancer Research medicine.medical_specialty business.industry non-small cell lung cancer (NSCLC) medicine.disease Carboplatin Gemcitabine chemistry.chemical_compound chemistry Internal medicine medicine business medicine.drug
Zdroj:	European Journal of Cancer Supplements. 1:S235
ISSN:	1359-6349
DOI:	10.1016/s1359-6349(03)90806-8
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::a9d16055a15340652d8fa970f2504f4b https://doi.org/10.1016/s1359-6349(03)90806-8 Zobrazit plný text záznamu Full Text from ScienceDirect